Nowak P, Jørgensen K, Mueller T C. "一种的合成方法" [P]. European Patent, EP 3169699 A1, 2017-08-04.
Lee S K, Hughes D C, Schröder R. "Method for the Synthesis of 1,3-Dimethyl-1-{3-methyl-[1,2]oxazolo[5,4-b]pyridine-5-carbonyl}urea" [P]. US Patent, US 11612967 B2, 2022-12-04.
发明人罗永刚,李文辉,孙丽萍. "A Process for Preparing High-Purity 1,3-Dimethyl-1-{3-methyl-[1,2]oxazolo[5,4-b]pyridine-5-carbonyl}urea" [P]. 中国发明专利, 专利号 CN 113256528 A, 授权公告日 2021-10-25.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Sci. Total Environ., 2017, 490, (8), 9830-9843.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Talanta, 2012, 1001, 8985-8988.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of 1,3-Dimethyl-1-{3-methyl-[1,2]oxazolo[5,4-b]pyridine-5-carbonyl}urea Using HRMS and NMR". Chromatographia, 2021, 425, (3), 7981-7999.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2010, 1990, 5213-5227.